Cargando…
Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma
Melanoma is a type of cancer with a relatively poor prognosis. The development of immunotherapy for the treatment of patients with melanoma has drawn considerable attention in recent years. It is of great clinical significance to identify novel promising prognostic biomarkers and to explore their ro...
Autores principales: | Xie, Jiaheng, Zhu, Zhechen, Cao, Yuan, Ruan, Shujie, Wang, Ming, Shi, Jingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279094/ https://www.ncbi.nlm.nih.gov/pubmed/34254872 http://dx.doi.org/10.1080/19336950.2021.1953322 |
Ejemplares similares
-
Database mining analysis revealed the role of the putative H(+)/sugar transporter solute carrier family 45 in skin cutaneous melanoma
por: Xie, Jiaheng, et al.
Publicado: (2021) -
A Novel Pyroptosis-Related lncRNA Signature for Predicting the Prognosis of Skin Cutaneous Melanoma
por: Xie, Jiaheng, et al.
Publicado: (2021) -
Analysis and update of the human solute carrier (SLC) gene superfamily
por: He, Lei, et al.
Publicado: (2009) -
The genetic landscape of the human solute carrier (SLC) transporter superfamily
por: Schaller, Lena, et al.
Publicado: (2019) -
Mechanistic basis of L-lactate transport in the SLC16 solute carrier family
por: Bosshart, Patrick D., et al.
Publicado: (2019)